Eli Lilly CEO: We're growing based on the back of our newest pharma products

7:14 AM ET Tue, 24 July 2018

David Ricks, Eli Lilly CEO, talks about the company's quarterly earnings, drug pricing pressure and the spin off its Elanco animal health unit.